Site navigation

Navigation

Transient loss of consciousness in adults

Management of transient loss of consciousness in adults

Status: In progress
Publication date: August 2010
Wave: 16
Process: CG
Topic area:
  • Central nervous system
 

NICE project team

Centre for clinical practice lead: Philip Alderson
Communications manager: Paul Cooney
Guidelines commissioning manager: Sarah Dunsdon
Guidelines coordinator: Laura Bruton
Patient involvement lead: Barbara Meredith
Implementation lead: Caroline Matenga
Lead collaborating centre: National Clinical Guideline Centre for Acute and Chronic Conditions
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Consultation on draft scope with stakeholders: 3 April - 1 May 2008
Scoping workshop: 24 April 2008
Consultation on draft guideline with stakeholders: 20 January - 17 March 2010
Pre-publication check: June 2010
Publication date: August 2010
Top


 

Project history

Date Update
29 February 2008 The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.
1 May 2008 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.    The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.
19 June 2008 The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. 
19 June 2008 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales above for dates of consultation with stakeholders.           
1 April 2009 Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre. Key contacts and timelines remain unchanged.
20 January 2010 The draft guideline is out for consultation with stakeholders.  If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
Top


 

Key documents

This page was last updated:   09 February 2010